Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Mularoni

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 22, 2020
Efficacy of β-lactam/β-lactamase inhibitors to treat extended-spectrum beta-lactamase-producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT-SOT Project)Ligia C Pierrotti, Elena Pérez-Nadales, Mario Fernández-Ruiz, et al.
Transplantation|July 25, 2024
Clinical Management and Outcomes of Nontuberculous Mycobacterial Infections in Solid Organ Transplant Recipients: A Multinational Case-control StudyFrancisco López-Medrano, Peggy L Carver, Sasinuch Rutjanawech, et al.
BMC Infectious Diseases|October 16, 2025
Cefiderocol therapy among immunocompromised adult patients: a descriptive analysis from a prospective, multicentre cohort studyAndrea Lombardi, Daniele Roberto Giacobbe, Davide Mangioni, et al.
Annals of Medicine|June 14, 2025
Mortality of <i>Pneumocystis jirovecii</i> pneumonia in intensive care units: a post-hoc analysis of an international multicenter study by ESGCIP and EFISGDaniele Roberto Giacobbe, Silvia Dettori, Vincenzo Di Pilato, et al.
Critical Care (London, England)|August 24, 2023
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISGDaniele Roberto Giacobbe, Silvia Dettori, Vincenzo Di Pilato, et al.
Infectious Diseases and Therapy|July 12, 2024
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort StudyDaniele Roberto Giacobbe, Laura Labate, Chiara Russo Artimagnella, et al.
Journal of Global Antimicrobial Resistance|June 18, 2019
Use of colistin in adult patients: A cross-sectional studyDaniele Roberto Giacobbe, Carolina Saffioti, Angela Raffaella Losito, et al.
Antimicrobial Agents and Chemotherapy|August 9, 2021
Propensity Score and Desirability of Outcome Ranking Analysis of Ertapenem for Treatment of Nonsevere Bacteremic Urinary Tract Infections Due to Extended-Spectrum-Beta-Lactamase-Producing <i>Enterobacterales</i> in Kidney Transplant RecipientsBelén Gutiérrez-Gutiérrez, Elena Pérez-Nadales, Salvador Pérez-Galera, et al.
Scientific Reports|October 22, 2025
Implementation of infection prevention and control components in Italian hospitals based on a nationwide survey on behalf of INSIEME projectMarianna Meschiari, Francesco Vladimiro Segala, Altea Gallerani, et al.
The Journal of Infection|April 4, 2026
Predictors of mortality and therapeutic efficacy in carbapenem-resistant Acinetobacter baumannii bacteremiaAlessandro Russo, Sara Palma Gullì, Antonio Vena, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 22, 2020
Efficacy of β-lactam/β-lactamase inhibitors to treat extended-spectrum beta-lactamase-producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT-SOT Project)Ligia C Pierrotti, Elena Pérez-Nadales, Mario Fernández-Ruiz, et al.
Transplantation|July 25, 2024
Clinical Management and Outcomes of Nontuberculous Mycobacterial Infections in Solid Organ Transplant Recipients: A Multinational Case-control StudyFrancisco López-Medrano, Peggy L Carver, Sasinuch Rutjanawech, et al.
BMC Infectious Diseases|October 16, 2025
Cefiderocol therapy among immunocompromised adult patients: a descriptive analysis from a prospective, multicentre cohort studyAndrea Lombardi, Daniele Roberto Giacobbe, Davide Mangioni, et al.
Annals of Medicine|June 14, 2025
Mortality of <i>Pneumocystis jirovecii</i> pneumonia in intensive care units: a post-hoc analysis of an international multicenter study by ESGCIP and EFISGDaniele Roberto Giacobbe, Silvia Dettori, Vincenzo Di Pilato, et al.
Critical Care (London, England)|August 24, 2023
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISGDaniele Roberto Giacobbe, Silvia Dettori, Vincenzo Di Pilato, et al.
Infectious Diseases and Therapy|July 12, 2024
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort StudyDaniele Roberto Giacobbe, Laura Labate, Chiara Russo Artimagnella, et al.
Journal of Global Antimicrobial Resistance|June 18, 2019
Use of colistin in adult patients: A cross-sectional studyDaniele Roberto Giacobbe, Carolina Saffioti, Angela Raffaella Losito, et al.
Antimicrobial Agents and Chemotherapy|August 9, 2021
Propensity Score and Desirability of Outcome Ranking Analysis of Ertapenem for Treatment of Nonsevere Bacteremic Urinary Tract Infections Due to Extended-Spectrum-Beta-Lactamase-Producing <i>Enterobacterales</i> in Kidney Transplant RecipientsBelén Gutiérrez-Gutiérrez, Elena Pérez-Nadales, Salvador Pérez-Galera, et al.
Scientific Reports|October 22, 2025
Implementation of infection prevention and control components in Italian hospitals based on a nationwide survey on behalf of INSIEME projectMarianna Meschiari, Francesco Vladimiro Segala, Altea Gallerani, et al.
The Journal of Infection|April 4, 2026
Predictors of mortality and therapeutic efficacy in carbapenem-resistant Acinetobacter baumannii bacteremiaAlessandro Russo, Sara Palma Gullì, Antonio Vena, et al.
Pageof 10